Europe Finance Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.

Press releases published on September 4, 2026

TOP Financial Group Limited Announces Strategic Relocation of Global Headquarters to the United States
Le fonds de revenu Canoe EIT annonce la distribution pour le mois de septembre 2026
Canoe EIT Income Fund Announces September 2026 Monthly Distribution
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nasdaq EVP & CFO Sarah Youngwood to Present at Barclays 24th Annual Global Financial Services Conference
Rush Enterprises and MCT Companies Complete Formation of Strategic Joint Venture
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Spyre Therapeutics Announces Grants of Inducement Awards
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
Premium Income Corporation Announces Monthly Distribution
Premium Global Income Split Fund Declares Monthly Distribution
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
Mulvihill Split Capital Share ETF Declares Monthly Distribution
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
Mulvihill Split Preferred Share ETF Declares Monthly Distribution

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Europe Finance Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.